NOMAX
ActiveSummary
NOMAX has been active since 2013 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.35M and a net result of €585k. Equity is growing by ~56.9% per year across the filed fiscal years. Its solvency ranks better than 78% of 8048 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100▲+6
Solvency98▲+5
Growth78=
Track record100
Bankruptcy probability, 12 months
0.5%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €110k at 30 days acceptable
Liquidity ample (current ratio 2.4 against 1.54 in 2024; short-term debt: 27.3% and cash: 24.6% of total assets), and 27.3% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
72.7%
Return on assets
31.6%
Age of the figures
12 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 30-04-2026, 0 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
on the day
2024
on the day
2023
1 d early
2022
3 d early
2021
2 d early
2020
on the day
2019
1 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today30-09-2026 close30-04-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€1.35M▲ 58.9%
2024 · €848k
Total assets
€1.85M▲ 47.6%
2024 · €1.26M
Net result
€585k▲ 131%
2024 · €254k
Working capital
€706k▲ 222%
2024 · €219k
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€222k▲ 102%€523k▲ 136%€107k▼ 79.5%€349k▲ 226%€873k▲ 150%
Net result€141k▲ 64.3%€370k▲ 163%€89k▼ 76.0%€254k▲ 185%€585k▲ 131%
Equity€330k▲ 74.6%€670k▲ 103%€678k▲ 1.2%€848k▲ 25.1%€1.35M▲ 58.9%
Total assets€530k▲ 39.8%€800k▲ 51.1%€875k▲ 9.4%€1.26M▲ 43.4%€1.85M▲ 47.6%
Debt€200k▲ 5.2%€131k▼ 34.8%€198k▲ 51.4%€407k▲ 106%€506k▲ 24.1%
Working capital€138k▼ 42.9%€40k▼ 71.0%€38k▼ 5.9%€219k▲ 483%€706k▲ 222%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 150% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.85M
Fixed assets
€642k ▲ 2.1%
Current assets
€1.21M ▲ 93.3%
Equity and liabilities €1.85M
Equity
€1.35M ▲ 58.9%
Debt
€506k ▲ 24.1%
Debt's share of the balance-sheet total falls from 32.4% to 27.3%. Equity and debt are higher.
Key figures and ratios
EBITDA
€907k▲
2024 · €378k
Cash flow
€619k▲
2024 · €282k
Current ratio
2.40▲
2024 · 1.54
Quick ratio
1.70▲
2024 · 1.36
Debt to equity
0.38▼
2024 · 0.48
ROE
43.4%▲
2024 · 29.9%
ROA
31.6%▲
2024 · 20.2%
Interest coverage
1629.53▲
2024 · 612.67
Debt ≤ 1 year
€505k▲
2024 · €407k
Income taxes
€299k▲
2024 · €106k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | €15 | - | €4k | €12k | ▲ 198% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €11k | €24k | €28k | €28k | €34k | ▲ 20.2% |
| Other operating charges640/8 | €3k | €734 | €684 | €1k | €1k | ▼ 5.1% |
| Non-recurring operating charges66A | - | €2k | - | €2k | €23 | ▼ 98.7% |
| Gross operating margin9900 | €235k | €550k | €136k | €381k | €908k | ▲ 139% |
| Operating profit (loss)9901 | €222k | €523k | €107k | €349k | €873k | ▲ 150% |
| Financial income75/76B | - | €574 | €8k | €11k | €12k | ▲ 7.1% |
| Recurring financial income75 | - | €574 | €8k | €11k | €12k | ▲ 7.1% |
| Financial charges65/66B | €935 | €780 | €533 | €616 | €556 | ▼ 9.7% |
| Recurring financial charges65 | €935 | €780 | €533 | €616 | €556 | ▼ 9.7% |
| Profit (loss) for the period before taxes9903 | €221k | €523k | €115k | €360k | €884k | ▲ 146% |
| Income taxes67/77 | €80k | €153k | €26k | €106k | €299k | ▲ 182% |
| Profit (loss) for the period9904 | €141k | €370k | €89k | €254k | €585k | ▲ 131% |
| Profit (loss) for the period to be appropriated9905 | €141k | €370k | €89k | €254k | €585k | ▲ 131% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €530k | €800k | €875k | €1.26M | €1.85M | ▲ 47.6% |
| Fixed assets21/28 | €242k | €645k | €641k | €629k | €642k | ▲ 2.1% |
| Tangible fixed assets22/27 | €242k | €269k | €265k | €253k | €266k | ▲ 5.2% |
| Plant, machinery and equipment23 | €3k | €28k | €24k | €22k | €27k | ▲ 22.3% |
| Furniture and vehicles24 | €37k | €41k | €52k | €53k | €72k | ▲ 36.4% |
| Other tangible fixed assets26 | €202k | €200k | €189k | €178k | €167k | ▼ 6.3% |
| Financial fixed assets28 | €90 | €376k | €376k | €376k | €376k | = |
| Current assets29/58 | €288k | €155k | €235k | €627k | €1.21M | ▲ 93.3% |
| Stocks and contracts in progress3 | - | - | - | €73k | €352k | ▲ 385% |
| Stocks30/36 | - | - | - | €73k | €352k | ▲ 385% |
| Amounts receivable within one year40/41 | €88k | €19k | €88k | €311k | €378k | ▲ 21.8% |
| Trade receivables40 | €81k | €287 | €37k | €267k | €352k | ▲ 31.8% |
| Other amounts receivable41 | €7k | €19k | €51k | €44k | €26k | ▼ 39.7% |
| Cash at bank and in hand54/58 | €109k | €104k | €137k | €226k | €456k | ▲ 101% |
| Deferred charges and accrued income490/1 | €91k | €32k | €10k | €17k | €25k | ▲ 49.5% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €530k | €800k | €875k | €1.26M | €1.85M | ▲ 47.6% |
| Equity10/15 | €330k | €670k | €678k | €848k | €1.35M | ▲ 58.9% |
| Contributions10/11 | €6k | €6k | €6k | €6k | €6k | = |
| Reserves13 | €323k | €664k | €672k | €842k | €1.34M | ▲ 59.3% |
| Non-distributable reserves130/1 | €2k | - | €2k | - | - | - |
| Reserves not available under the articles1311 | €2k | - | €2k | - | - | - |
| Distributable reserves133 | €322k | €664k | €670k | €842k | €1.34M | ▲ 59.3% |
| Amounts payable17/49 | €200k | €131k | €198k | €407k | €506k | ▲ 24.1% |
| Amounts payable after more than one year17 | €35k | - | - | - | - | - |
| Financial debts170/4 | €35k | - | - | - | - | - |
| Amounts payable within one year42/48 | €150k | €115k | €197k | €407k | €505k | ▲ 24.1% |
| Current portion of amounts payable after more than one year42 | €7k | €2k | - | - | - | - |
| Financial debts43 | €20k | €2k | - | - | - | - |
| Credit institutions430/8 | €20k | €2k | - | - | - | - |
| Trade debts44 | €116k | €26k | €6k | €157k | €121k | ▼ 22.7% |
| Suppliers440/4 | €116k | €26k | €6k | €157k | €121k | ▼ 22.7% |
| Advances received on contracts in progress46 | - | - | €32k | - | - | - |
| Taxes, remuneration and social security45 | €8k | €55k | €64k | €104k | €281k | ▲ 171% |
| Taxes450/3 | €5k | €53k | €64k | €104k | €271k | ▲ 161% |
| Remuneration and social security454/9 | €3k | €2k | - | - | €10k | - |
| Other amounts payable47/48 | - | €30k | €96k | €147k | €103k | ▼ 29.7% |
| Accrued charges and deferred income492/3 | €15k | €15k | €490 | €137 | €137 | = |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €141k | €370k | €89k | €254k | €585k | ▲ 131% |
| + Depreciation and write-downs630 | €11k | €24k | €28k | €28k | €34k | ▲ 20.2% |
| Operating cash flow (approximation) | €152k | €394k | €117k | €282k | €619k | ▲ 119% |
| Investment in fixed assets (approximation) | - | €-427k | €-23k | €-17k | €-47k | ▼ 182% |
| Change in cash | - | €-5k | €33k | €90k | €230k | ▲ 156% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-04
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
30-09
Financial
Highest result since 2018net €585k ▲131%
Operating result €873k, net result €585k, both a record.
30-09
Financial
Equity above €1MEq €1.35M ▲58.9%
8 profitable years in a row build equity to €1.35M.
30-04
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
29-04
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
27-04
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
30-09
Financial
Equity above €500kEq €670k ▲103%
5 profitable years in a row build equity to €670k.
28-04
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
30-09
Financial
Equity above €200kEq €330k ▲74.6%
4 profitable years in a row build equity to €330k.
30-04
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
30-09
Financial
Liquidity triplescurrent ratio 3.92
Current ratio from 1.50 to 3.92; short-term debt falls from €164k to €83k.
30-09
Financial
Equity above €150kEq €189k ▲83.1%
3 profitable years in a row build equity to €189k.
Show earlier events
29-04
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
30-09
Financial
Equity above €100kEq €103k ▲80.3%
2 profitable years in a row build equity to €103k.
30-04
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
30-04
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
29-05
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zutendaal · 1 establishment unit since 2013
Ground area
902 m²
Building footprint
197 m²
Volume, LiDAR
1,185 m³
Parcel 71582C0087/02P000, Flanders · tallest building 8.4 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
NOMAX
since 20132.219.895.181
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71582C0087/02P000 | Flanders | 902 m² | 1 · 197 m² | 8.4 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DENTAL DISCOVERY
BE 0882.309.822
Sint-Niklaas · Eq €1,341,473
EPPENDORF BELGIUM
BE 0434.253.657
Aarschot · Eq €1,356,630
INVACARE
BE 0458.249.477
Zedelgem · Eq €1,338,020
DENTAL DISCOUNT
BE 0445.781.019
Beersel · Eq €1,358,552
Pharma & More
BE 0774.831.545
Destelbergen · Eq €1,336,405
Of 1,902 companies in sector 46460 we hold annual accounts for 1,116. 740 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded14-06-2013
Fiscal year end30-09
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
86910Medical imaging and medical laboratories
Scores and ratios are computed by Checked and are not a credit decision.